LODALIS
Google image searchProduct monograph
Active ingredient
colesevelam hydrochloride, 3.75 G/SACHET
DIN: 02432463
Dosage form(s): POWDER FOR SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 09-DEC-2020
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AC — Bile acid sequestrants (ATC, ATC/DDD)
- C10AC04 — COLESEVELAM (ATC/DDD)
Reference brand drug: Lodalis
